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1. Introduction 
Although thyroid hormone effects on the brain are most prominent in development, also in 
adult-acquired hypothyroidism symptoms such as sensory impairments, disagreeable 
smells and taste, slowness of thought and action, changes of speech, irritability, headaches, 
sleep disturbances, confusion up to delusions and hallucinations, impairments of memory, 
of vision as well as of hearing frequently occur. This involvement of the nervous system was 
already discussed in the first reports on myxoedema (1–3) and a systematic description 
included in the first extensive investigation by the Committee of the Clinical Society of 
London (4). Many of these symptoms have since been studied in considerable detail. The 
conspicuous slowing of movements of hypothyroid subjects has been shown to correlate 
with peripheral sensory and motor nerve dysfunctions and abnormal neuromuscular 
transmission (5–10). The slowing of thoughts and mental function occurs concomitant with a 
decrease in the frequency of the alpha rhythm of the EEG (11–15). In addition to the slowing 
of the alpha-rhythm increased latencies of visual, auditory and somatosensory evoked 
potentials in adult-onset hypothyroidism indicate a slowed conduction of information in the 
central nervous system (16–24). In addition to a slowing of neuronal conduction velocity, 
changes in the threshold of hearing (25–29) and of the sensation of smell have been reported 
(30, 31). Cognitive and memory tests revealed impaired performances, which could at least 
partially be reversed by hormone substitution (24, 32–34). The extent of the reversibility of 
these symptoms is still a matter of debate (35).  
Since many of the neurological symptoms observed in hypothyroidism point to a 
conspicuous mental slowing as leading symptom of hypothyroidism, we here were 
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interested to test in a small sample of 6 patients, whether already a transient hypothyroid 
state, induced by 4 weeks of total thyroid hormone withdrawal, would result in detectable 
changes in the speed of sensory perception and cognitive functions. For this aim we 
combined different psychophysical tests shown to be sensitive in previous studies of 
hypothyroidism with some new examinations. While cognitive tests, such as the trail 
making test as well a calculation task showed a non-significant tendency toward slowing, a 
more complex visual- spatial performance test revealed a significant slowing of mental 
function after four weeks of hypothyroidism. The speed of speech was significantly reduced 
and a fast Fourier analysis showed a shift to lower frequencies in the hypothyroid test 
persons. A significant decrease in red-green colour fusion frequency was found, indicating 
an impaired temporal resolution of visual stimuli. Smelling of two odorants tested, odorant 
discrimination (Sniffin`sticks) and the hearing thresholds were slightly, but insignificantly 
impaired in the hypothyroid test persons. The results of these tests indicate that the most 
prominent and first significant clinical symptom to develop in hypothyroidism is a slowing 
of speech and of visual perception. 
Slowing of conduction velocity can be explained by a reduced myelination. A second 
mechanisms is a decrease in voltage-gated sodium current density, leading to a slowed 
charging of the membrane capacitor thus resulting in a decreased slope of the action 
potential upstroke velocity which in turn decreases conduction velocity. Although several 
investigations support the concept that thyroid hormone affects myelination, recently 
evidence has accumulated, that thyroid hormone also increases sodium current density in 
neurons from several species. We will thus discuss reports on the regulation of voltage 
gated ion currents in neurons and muscle cells later in the chapter, which could offer an 
explanation for the observed slowing of thoughts and movements at the cellular and 
molecular level. 
Furthermore, it has been known for a long time, that thyroid hormone regulates energy 
expenditure (see also Yehuda-Shnaidman et al. in this issue). Pumping of Na+ out of the cells 
has been accounted for the expense of 40% of energy consumed at rest (36, 37). Thus an 
increased influx of Na+ due to enhanced voltage-gated Na+-influx will most likely also 
stimulate Na+/K+-ATPase activity, and could also account at least to some extent for the 
stimulation of an enhanced expression of Na+/K+-ATPase subunits in the membranes. We 
thus conclude the chapter by reviewing data on the regulation of Na+/K+-ATPase by thyroid 
hormone in the brain and its potential link to Na+ current regulation. 
2. Clinical symptoms during transient severe hypothyroidism quantified 
by psychophysical investigations in adult human test persons 
To illustrate some conspicuous effects of thyroid hormone on brain function we studied 6 
patients after total thyroidectomy for thyroid carcinoma who had discontinued taking 
thyroid hormone prior to routine diagnostic 131I- scanning and who thus showed a 
reproducible degree and duration of hypothyroidism. Symptoms described to occur a few 
weeks after discontinuation of thyroid hormone therapy are changes in peripheral 
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conduction velocity and in the EEG (15). Furthermore, subjective impairments of the quality 
of life (38–40) as well as changes in mood (41, 42) and decreases in working memory (43) 
have been reported. 
3. Methods 
Test persons. A test battery was developed to allow a relatively fast examination of several 
aspects of sensory and cognitive function. To integrate the investigation into the normal 
clinical examination procedures the whole testing protocol was designed to be completed 
within 1.5 hours. All tests were carried out on 6 patients after thyroid hormone withdrawal 
for 26 to 28 days and on 6 healthy volunteers which were age (maximal difference: 3 years) 
and sex matched (with the exception of one female control person for a male patient). 
Patients were retested after at least 6 weeks of hormone substitution, after obtaining low TSH 
values. To elaborate the optimal test parameters some of the tests had been performed in more 
detail on an additional hypothyroid test person, the data of which are included in the 
appropriate results sections. In the 7 test persons (age 42-64, 4 female, 3 male) TSH-suppressive 
thyroid hormone substitution after total thyroidectomy and radioiodine therapy for thyroid 
carcinoma had been discontinued for 26-28 days for routine diagnostic application of 131I. 
Thyroid hormone levels measured in hypothyroidism were FT3: < 2.0 pmol/l, FT4: <2.6 pmol/l 
in 6 patients and FT3: 2.6 pmol/l, FT4: 4.8 pmol/l in the remaining patient, TSH was > 80 mU/l 
in three patients and 48.7 ± 10.4 mU/l (mean ± SE) in the remaining four patients. After 6 - 10 
weeks of hormone substitution these values were: FT3: 6.2 ± 0.5 pmol/l, FT4: 26.0 ± 3.0 pmol/l 
and TSH: 0.09 ± 0.04 mU/l, n=7 (normal ranges: FT3: 3.4 - 7.6 pmol/l (SPART, Amerlex MAB, 
Johnson & Johnson); FT4: 11 - 23 pmol/l (SPART, Amerlex MAB, Johnson & Johnson), TSH: 0.3 
- 4.0 mU/l (IRMA, Dynotest, Brahms). Results are given as means ± standard error. Statistical 
analysis was performed using paired Student`s t-test. Informed consent was obtained from all 
individuals before performing the tests. 
Speed of speech. To investigate possible changes in the speed of speech we asked the test 
persons to repeat four times the same word as fast as possible (in this case the word 
„Apfelmus“). They were asked the repeat the series of four words four times and were 
encouraged to accelerate their speech as much as possible. The four series of words were 
stored on magnetic tape with a SONY WTC-D6C stereo cassette recorder and analysed off-
line using a Digidata 1200A analog-digital converter with “Axoscope” software (Axon 
Instruments). The time needed to pronounce the four words was then read from a digital 
storage oscilloscope. In addition a fast Fourier analysis was performed on the record of the 
second syllable (“mus”) selected from the two fastest traces obtained from each test person 
in the hypothyroid and the euthyroid condition. The section of the record to be analysed 
was selected with “Axoscope” and then analysed with “Origin 5” software. 
Tests of cognitive performance:  
a. Calculation and Correlation. To test more complex mental performances patients were 
first handed a sheet of paper and asked to complete a set of 24 simple calculation tasks 
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of third grade difficulty (like: 23+11=?). Each result of a calculus task was assigned one 
of five colours (yellow, red, green, dark and light blue). After completing the calculation 
task the test persons were asked to fill a second form, consisting of an outline drawing 
containing 54 numbered areas, where each number equalled one of the results of the 
preceding calculus task (some numbers were used several times). The patients were 
handed coloured pencils and asked to assign the appropriate colour from the result of 
the calculus task to each of the numbers given in the drawing. This procedure finally 
resulted in the appearance of a meaningful picture (in this case a boat). The time taken 
by the patients to complete the calculus task and to assign the colours to the figures in 
the drawing was monitored.  
b. Trail making. The test consisted of a piece of DIN A4 paper, containing randomly dis-
tributed numbers (24 pt size, black, surrounded by a black circle). The paper was placed 
on a table in front of the test persons who were asked to connect the numbers from one 
to 25 (version A). In version B numbers from 1 to 13 and letters from A to L were 
distributed randomly and the test persons asked to connect them alternating between 
the numbers and the succession of the alphabet, e.g., 1-A 2-B- 3-C etc. The time needed 
for completion of the test was recorded (44).  
Tests to determine time resolution of visual perception and colour contrast perception: 
a. Flicker fusion frequency. Light flashes delivered with a sufficiently high frequency fuse to 
give the impression of a continuous light source. The lowest frequency at which an in-
termittent light source is perceived as a continuous one is termed the „flicker fusion fre-
quency“. A light source containing red (660nm), green (565 nm) or blue (470nm) diodes 
of 1 cm2 diameter with an intensity of 14 Cd m2 (determined with a Minolta luminance 
meter) was displayed to the test persons at a distance of 52 cm (to excite a 1° area of the 
visual field). The screen was positioned at the back of a 50 x 50 cm wide and 52 cm deep 
box with black walls. The flicker frequency was generated with a square wave pulse 
generator with a 50% duty cycle. The frequency could be changed with a dial. Test 
persons were asked to focus on the light with both eyes while the frequency was 
increased and to give a sign when they perceived the flashes to fuse to a continuous 
light source. Since it turned out to be too time-consuming to test the right or the left 
eyes, foveal and peripheral illumination separately and to use lights of different colours 
and since preliminary experiments showed no qualitative differences in the results, 
most patients were only retested with the red colour fixed by two eyes. The average 
value of three determinations of flicker fusion frequency always starting from low 
frequencies was determined. 
b. Red-Green fusion. Changes in the perception of chromatic flicker were tested in addition 
to the critical flicker fusion frequency of luminance flicker. In this test a rotating disk of 
12 cm diameter was shown to the test persons. The disk was diagonally partitioned into 
four sections which were painted alternatively in light red (Plaka Nr. 82) and light 
green (Plaka No. 90; 16 – 20 Cd/m2, determined with a Minolta LS 100 luminance 
meter). The speed of rotation was increased continuously and the number of rotations 
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per minute was electronically counted. Increasing the speed of rotation first gave the 
impression of a luminance flicker. A further increase in the speed of rotation resulted in 
the impression of a homogenous dark yellow colour. The patients were asked to give a 
sign at the frequency were they saw the first signs of a luminance flicker and as soon as 
they perceived the impression of a homogenous yellow colour. Each test was repeated 
three times starting with low frequencies and the average value of the three 
determinations was noted. 
Sense of Smell. Two tests were used to detect possible changes in the sense of smell: First a 
test for the recognition and discrimination of 16 different odorants, including familial smells 
like cinnamon and rather unusual flavours, like leather, was used. Then the threshold of 
perception was tested using two different odours, one that tests the excitation of the 
olfactory nerve (phenylethyl alcohol (Phe)), smelling like rose, and one, exciting both, 
trigeminal and olfactory nerves (eugenol (Eu)), Sniffing´sticks, (45)). In brief, for the odorant 
tests, caps were removed from plastic sticks containing odorants of different concentrations 
filled into the sticks ending in felt tips extruding about 5 mm from the tip of the stick. A 
stick was gently moved at a distance of about 1 cm below the nostril of the test person. 
Sticks containing the test solution in ascending concentration (descending numbers on the 
stick) were presented to the test person in series of three sticks, two of which contained 
distilled water. The threshold was defined as the concentration at which the patient 
correctly recognised the odour in two out of three presentations.  
Hearing threshold. Hearing thresholds were determined for 8 different frequencies using an 
Ascom Audiosys Maico ST20 audiometer. Changes in threshold for sinusoidal tones of 1 
and 8 kHz were evaluated. 
3.1. Experimental results 
Speed of speech. Figures 1A and B show digitized traces of speech records of a female test 
person in hypothyroidism (upper trace, a) and after hormone substitution (lower trace, b). 
After hormone substitution this test person pronounced the four words faster. As shown in 
Fig. 1C, on average the test persons needed a significantly longer time to pronounce the 
same words in the hypothyroid condition as compared to the euthyroid control persons or 
after thyroid hormone substitution. Figure 1D gives a more elaborate example of the 
development of the slowing of speech during hormone withdrawal and resubstitution. Here 
an additional test person was asked to repeat a short poem in regular intervals at maximal 
speed and the time taken to complete this poem was recorded. During hormone withdrawal 
the time needed to finish the poem became increasing longer. During resubstitution with 
thyroid hormone the time to finish the poem gradually decreased during the following 
month. To find out whether the increase in speed of speech during hormone resubstitution 
was accompanied by an increase in pitch a fast Fourier analysis was performed on the 
syllable “mus” (encircled by the rectangles in Fig. 1A). The analysis of the pronounciation of 
this syllable, consisting with predominant amplitude of the noun “u” showed several clear 
frequency peaks (Fig. 1B). The records from four of the five male subjects included in the 
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study showed a peak between 100 and 200 Hz which was not seen in the records from any 
of the female test persons. Since the most prominent peak in all test persons was found 
between 200 and 300 Hz this peak was evaluated in hypothyroidism and after hormone 
substitution. As shown in Table 2 and illustrated in Fig. 1B the peak frequency was shifted 
by an average of about 30 Hz to higher frequencies by the hormone substitution. This shift 
was found in all subjects with the exception of one test person, aged 61, who suffered from 
paresis of the n. recurrens.  
 
Figure 1. Changes of speech during thyroid hormone withdrawal. Original voltage traces of a record from a 
female test person (A) repeating four times the word “Apfelmus” as fast as possible after four weeks of 
thyroxine withdrawal (a) and after 10 weeks of hormone resubstitution (b). The darker yellow shadow 
indicates the time needed to pronounce the first word in the hypothyroid condition. B: Fast Fourier 
analysis of sections of the speech record shown within the squares in A. Inset: 100 ms long sections from 
the analysed traces. C: average time needed to pronounce the four words after hormone withdrawal 
(Hypo), resubstitution (Eu) and by control subjects (mean ± SE, n=6) asterisk: p<0.05, 2 asterisks: p<0.01. 
D: time needed to complete a short poem of an additional test person recorded daily during last 20 days 
of thyroxine withdrawal and during the following 60 days of resubstitution. Note the gradual decline in 
speed of speech with increasing time of thyroid hormone withdrawal. 
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Speed of visual perception. In hypothyroidism, the frequency, at which patients first 
reported to perceive a flickering light source as a continuous one was slightly but 
insignificantly smaller than the frequency determined in the control group. The 
hypothyroid group showed no significant improvement after 6 weeks of hormone therapy 
(Figure 2Ab). In a single test person, where the flicker fusion frequency was recorded 
daily for blue, green and red light and both eyes tested separately, however, a significant 
decrease in flicker fusion frequency was shown in the third week after the arrest of 
hormone substitution. After six weeks of hormone resubstitution the flicker fusion 
frequency had significantly recovered with respect to the last week without the hormone 
(Table 1 and Figure 2 Aa).  
 6 days during 
first week of 
thyroid hormone
withdrawal 
Days 17-22 of 
hormone 
withdrawal 
P (1st week 
versus 3rd 
week) 
40-46 days after 
beginning of 
thyroid hormone 
resubstitution 
P (6 weeks after 
resubstitution 
versus 3 weeks 
after hormone 
withdrawal) 
 n mean SEM n mean SEM  n mean SEM  
CFF (Hz), 
green 
2600 Cd/m2 
12 37.4 0.4 12 36.6 0.6 0.27 12 40.6 0.3 0.000006 
CCF (Hz), 
red 
100 Cd/m2 
12 35.8 0.6 12 32.8 0.4 0.0003 12 36.3 0.3 0.0000002 
CCF (Hz), 
blue 
30 Cd/m2 
12 35.3 0.6 12 29.9 0.5 0.0000004 12 37.2 0.3 <0.0000000001 
Table 1. Critical flicker fusion frequency for three different colours (12 measurements on 2 eyes 
determined on 6 successive days were pooled from one test person, SEM: standard error of the mean, 
unpaired t-test), the original data for red light are displayed in Figure 2Aa. 
The critical colour fusion frequency (CCFF), determined with a rotating wheel of alternating 
green and red sectors was significantly reduced in the hypothyroid test persons compared 
with the control subjects. The frequencies at which the rotating, red-green disk was 
perceived as starting to show a luminance flicker (Fig. 2 Ba) as well as the frequency at 
which a uniform yellow colour was reported (Fig. 2Bb) were both significantly smaller in the 
hypothyroid test persons as compared to the control group.  
Cognitive performance. Since several cognitive tests have been shown to be sensitive for 
thyroid hormone we here tested whether hypothyroidism for 4 weeks has an effect on 
calculation and visual-spatial orientation. A slight but insignificant slowing of the speed 
with which the hypothyroid persons completed the calculation task compared with the 
euthyroid control group was observed (Table 2, Figure 3A). A stronger effect was seen, 
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however, if a more complex performance task, like the correlation of numbers with colours 
and finding and colouring the appropriate numbered area, had to be accomplished (visual-
spatial orientation). Here the hypothyroid patients performed somewhat slower than the 
control subjects. After 6 weeks of hormone substitution the formerly hypothyroid persons 
showed a significantly improved performance (Figure 3B). Hypothyroid persons completed 
the trail making test insignificantly slower than the euthyroid controls or after hormone 
substitution, (Figure 3C, D). 
 
Figure 2. Speed of visual perception. Aa: critical flicker fusion frequency for a luminance flicker of red 
light, 100 Cd/m2 measured once daily at the same time in the morning in a test person during the last 20 
days of thyroxine withdrawal and during resubstitution. Note the gradual continuous decrease in CFF 
with increased time of thyroxine withdrawal and the gradual increase after hormone resubstitution. 
Dark red symbols: right eye, light red symbols: left eye. Ab: average critical flicker fusion frequency 
determined in six separate test persons after four weeks of hormone withdrawal (green bars), 
resubstitution (violet bars) and in control subjects (pink bars). B: critical colour fusion frequency in same 
test persons for luminance flicker of red and green sectors of a rotating disk (a) and fusion of the red-
green sectors to homogenous yellow (b) (mean ± SE, n=6) asterisk: p<0.05. 
Hearing threshold. Since thyroid hormone has been reported to also affect the auditory 
system here we tested whether thyroid hormone withdrawal for several weeks has a 
measurable effect on hearing thresholds. No changes in hearing threshold were obvious for 
frequencies below 8 kHz. Hence only the measurements at 1 kHz and 8 kHz were evaluated 
(Table 2). If data from both ears were pooled, the improvement of 8 dB seen after hormone 
substitution at the test frequency of 8 kHz just reached significance. 
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Figure 3. Performance in cognitive tests. A: Average time needed by test persons after four weeks of 
hormone withdrawal (light bars), thyroid hormone resubstitution for at least nine weeks (grey bars) and 
by control subjects (black bars) to complete a set of simple calculations. B: Average time needed by the 
same subjects to combine numbers in an outline drawing with corresponding colours. C: Average time 
needed by the same subjects to complete the Trail A test and D: the Trail B test (mean ± SE, n=6). 
Asterisk: p<0.05 
Sense of smell. Finally, thyroid hormone might also affect the sense of smell. Of the six test 
persons tested one had been anosmic since childhood and a second subject did not want to 
repeat the smelling threshold test. Hence only 4 persons could be retested in the euthyroid 
state (Table 2). Using the odorant discrimination task, the hypothyroid test persons rated 
66% of the presented flavours correctly. After hormone substitution they showed a slightly 
increased performance rating 72% of the presented flavours correctly, while the controls 
gave 70% correct answers. After four weeks of hypothyroidism, small but insignificant 
decreases in the threshold of odorant detection were found for both odorants which were 
still below the thresholds determined for the control subjects (Table 2). 
Age-dependence of thyroid hormone effects 
Although hypothyroid subjects performed on average slower in several tests it could have 
been possible that some test persons showed only a slowing of speech while others 
showed a slower resolution of visual signals. To find out whether some subjects were on 
average, slower or faster than others for each of seven tests, the speed of speech, 
calculation time, picture filling, Trail A, Trail B, critical flicker fusion frequency for red 
luminance flicker and fusion frequency for chromatic flicker, all twelve test persons were 
assigned numbers of 1 to 12 for each test, were the fasted was scored with 1 and the 
slowest with 12. If two persons showed the same speed of performance they were 
assigned an equal score, such that the highest value was less than 12 for several tests. For 
each test person the average score in the seven tests was calculated (Fig. 4). If differences 
in performance in the different tests were random, then the scores would scatter around a 
value of somewhere below 6.5 (assuming that in some tests several test persons showed 
the same speed). As Fig. 4 shows, this was not the case. As expected, the hypothyroid test 
persons were on average slower than the control subjects (Fig. 4A). As also somewhat 
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expected the speed of performance showed a tendency to decline with age, such that the 
older test persons, displayed at the right side of the series of columns in Fig 4A, scored on 
average higher than the younger subjects. In comparison of the performance of the test 
persons during hormone substitution with the control subjects an increase in overall 
speed of performance of the formerly hypothyroid subjects was seen, such that the 
average speed of the substituted test persons became indistinguishable from that of the 
controls (Fig. C). Interestingly, the relative increase in speed seemed to be larger in the 
younger than the older test persons (compare Fig. 4A with Fig. 4B).  
 Hypothyroid 
Test Persons 
(HypoTP) 
Substituted 
Test Persons 
(SubTP) 
P (HypoTP 
versus 
SubTP) 
Controls P (HypoTP 
versus 
Controls) 
 n mean SEM n mean SEM  n mean SEM  
Speed of speech / s 12 2.09 0.05 12 1.91 0.04 0.03 12 1.88 0.05 0.003 
Pitch of „u“ /Hz 12 236 13 12 263 10 0.008 12 264 10 0.16 NS 
CFF /Hz 6 28.3 1.0 6 28.2 1.1 0.90 NS 6 30.3 1.6 0.38 NS 
CCFF I /Hz 6 22.0 1.2 6 23.0 2.1 0.73 NS 6 27.3 2.4 0.03 
CCFF II /Hz 6 26.2 1.8 6 30.8 1.8 0.21 NS 6 31.8 2.3 0.02 
Calculation time /s 6 146 42 6 142 40 0.75 NS 6 118 19 0.51 NS 
Visual-spatial 
orientation/s 
6 576 56 6 478 71 0.02 6 504 74 0.44 NS 
Trail A /s 6 122 25 6 105 26 0.16 NS 6  96 16 0.40 NS 
Trail B /s 6 203 40 6 163 44 0.13 NS 6 189 36 0.79 NS 
Odour recognition 
(%) 
5 66 6 5 72 6 0.32 NS 5 70 6 0.48 NS 
Smell threshold 
(eugenol) 
5 6.7 0.6 4 6.9 1.2 0.91 NS 5 7.8 0.5 0.19 NS 
Smell threshold 
(Phe) 
5 5.9 1.1 4 6.7 0.5 0.54 NS 5 7.8 0.5 0.23 NS 
Smell threshold 
(Pyr) 
5 5.1 0.5 4 5.4 0.8 0.37 NS 5 5.9 1.1 0.50 NS 
Hearing threshold 
for 8 kHz /-dB 
12 32 5 12 24 6 0.05 12 25 4 0.24 NS 
Hearing threshold 
for 1 kHz /-dB 
12 22 3 12 21 4 0.43 NS 12 23 2 0.83 NS 
Speed and pitch of speech: the two fastest measurements of each test and control persons were included. CFF: critical 
flicker fusion frequency, CCFF: critical colour fusion frequency, Smell thresholds: a lower threshold of smell 
corresponds to a higher test score: Phe: Phenylethylalcohole, Eu: Eugenol: Pyr: pyridine, hearing thresholds: data from 
right and left ears were pooled, SEM: standard error of the mean, paired t-Test 
Table 2. Summary of the effects of hypothyroidism on performance in the different psychophysical 
tests in hypothyroid test persons, hormone substituted hypothyroid test persons and euthyroid control 
subjects. 
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Figure 4. Effects of age and thyroid status on speed of performance of individual test persons. Mean scores 
obtained by the 12 test and control subjects in 7 tests. A: Comparison of speed of performance in the 
sum of 7 tests in hypothyroid subjects with control subjects. Smallest score: fastest person, largest score: 
slowest person. B: Comparison of former hypothyroid subjects after at least 6 weeks of hormone 
substitution (a) with controls (b). C: Mean values of scores of all six persons after thyroid hormone 
withdrawal compared with control subjects (a) and of test persons after hormone replacement with 
controls (b). Light bars: test persons after hormone withdrawal, grey bars: test persons after hormone 
resubstitution, black bars: control subjects.**: p<0.01.D: Overall improvement in speed of performance 
after hormone substitution. For each of the 6 test persons the number of tests in which performance was 
speeded minus the number of tests in which performance was slowed was determined (maximal value 
of improvement: 8, maximal value of slowing: -8). While 5 persons considerably increased their speed of 
performance (e.g. an increase in speed in 6 tests and a decrease in performance in 1 test) only 1 test 
person showed no average increase in speed.  
To investigate whether only the younger test persons responded with an increase in the 
speed of neuronal information processing to thyroid hormone we evaluated the individual 
change in performance of each test person. For each of the 6 test persons and eight tests (the 
speed of speech, pitch of speech, calculation time, picture filling, Trail A, Trail B, critical 
flicker fusion frequency for red luminance flicker and fusion frequency for chromatic flicker) 
we rated an increase in the speed of performance in a test assigning a 1 to an increase in 
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speed, a 0 for an unchanged performance and a –1 for a slowing of performance at retesting 
during hormone resubstitution. If a person showed no overall change in speed of 
performance, a score scattering around 0 should result, if the subject slowed considerably 
the score should be in the negative range and if a subject speeded in all tasks, the maximal 
score would reach 8. As depicted in Fig. 4D out of the 6 persons tested with all 8 identical 
tests 5 showed a considerable speeding which corresponded to an increased performance in 
at least 6 out of 8 tests. Only one of the test persons, aged 57, showed an increased 
performance in only 4 tests and a decreased performance in 4 tests. This person was the only 
one who showed no increase in the speed of speech with thyroid hormone substitution. 
Nevertheless Fourier- analysis revealed an increase in pitch by 11% after prolonged 
hormone resubstitution in this test person.  
Our findings, that younger persons are more impaired than older subjects after thyroid 
hormone withdrawal is in accordance with recent findings by Heinzel et al., who reported a 
stronger subjective impairment in younger patients after thyroid hormone withdrawal than 
in older patients (46). This is in accordance with observations of age-dependent effects on 
heart action potential parameters observed to parallel age-related thyroid states (47, 48). 
This observation might relate to a down-regulation of thyroid hormone receptors with aging 
(49). 
4. Evaluation of the experimental data in the context of previous 
observations of the action of thyroid hormone on mental speed 
Taken together, this short survey of measurable changes in sensory perception and reaction 
after a period of a few weeks of severe hypothyroidism indicates that the first effects of 
hypothyroidism to become significantly evident concern changes in the speed of speech and 
visual perception. 
Speed of speech 
Although slowing of speech and thinking had already been noticed in the first description of 
myxedema (2) and by the Committee of the Clinical Society in 1888 (4) to be one of the most 
prominent symptoms of hypothyroidism we are aware of only one published attempt to 
quantify changes in speech due to different thyroid states. This study reported a negative 
correlation between the basal frequency of speech and the duration of the achilles tendon 
reflex (50). These authors performed investigations before and after treatment of hypo- and 
hyperthyroidism with reported time intervals from 7 days to 17 weeks, but did not further 
comment on the severity of thyroid dysfunction and the time course of development of 
recovery of the changes in pitch. A further study observed a decrease of the fundamental 
frequency of speaking 4 days after thyroid ablation (51). Although the cause for the slowing 
of speech is difficult to interpret, increased intervals between the different words (see Fig. 
1A) suggest, that in addition to a possible slowing of muscle contraction and a potential 
decrease in tension of the vocal cords a central slowing of neuronal information processing 
is likely to occur. 
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Speed of processing of visual signals 
The second most prominent effect of hypothyroidism revealed by our tests is a slowing of 
the speed of perception of visual information. These results confirm several previous 
studies, one of which reported critical flicker fusion frequencies (CFF) up to 41 - 48 Hz in 23 
hyperthyroid patients and a decrease in flicker fusion frequency to the normal value of 37 
Hz within one month after treatment of the hyperthyroidism (52). Decreased values of the 
critical flicker fusion frequency as well as of the maximal speed of finger movements were 
shown in hypothyroid patients (53). A third study revealed an increase in CFF in 
hypothyroid subjects with a delay of 2-3 weeks after an increase in dose of thyroid hormone 
substitution (54). We could find no previous reports on influences of thyroid hormone on 
the critical colour-fusion frequency (CCFF) which tests the speed of processing of chromatic 
pathways in addition to the CFF, which tests the speed of luminance processing. CCFF 
occurs at a lower frequency as CFF (55). The lower frequency of colour processing compared 
to luminance flicker already starts to arise at the level of the retina (56). 
Since thyroid hormone affects the renewal rate of the photoreceptor outer segments in the 
rat (57, 58) one locus of action of thyroid hormone could be the retina. This is confirmed by 
the finding of increased amplitudes of chiefly the b-waves of the electroretinogram in 
hyperthyroidism and a decrease in hypothyroidism (59, 60), suggesting that thyroid 
hormone influences retinal sensitivity to light. Since there is evidence that thyroid releasing 
hormone (TRH) in the circulation decreases the critical flicker fusion frequency (61) the 
effect could also be due to the enhanced TRH level in the investigated test persons. Since, 
however, no effects of hypothyroidism on peripheral circulating TRH values have been 
found (62) it seems presently more likely that the decrease in flicker fusion frequency is due 
to a direct effect of thyroid hormone.  
Increased voltages of EEG records and a decreased duration of arousal responses to photic 
stimulation after administration of thyroid hormone (63) could be explained by an increased 
light-sensitivity of the retina, but additionally also by an increased transmission of sensory 
signals to the visual cortex. Substantial experimental evidence has been obtained to show 
that the upper frequency limit with which signals are transmitted in the visual pathways 
decreases with the number of synaptic stations traversed (for review see (64)). Hence a 
modulation of synaptic transmission at the thalamic level seems to be responsible for the 
increase of CFF by psychotropic stimulants and the decrease by sedatives (for reviews see 
(65, 66)). Furthermore, investigations of the relation between CFF and intelligence revealed 
only non-significant relations between different scores for intelligence and CFF (67, 68), 
however a decrease of 4 Hz of was found in mentally retarded persons (69) suggesting that a 
larger decline of cognitive function may be accompanied by decreases in CFF. In addition a 
correlation was found between the decline of CFF and the decline in performance on 
cognitive tests in old age (70). 
Complementary to a reduction in CFF, flash evoked potentials showed increased latencies 
and reduced amplitudes in hypothyroid patients 6 weeks after thyroidectomy which were 
reversed after 8 weeks of treatment (16). Consistently, visual evoked potentials using 
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chequerboard reversal patterns showed reversible increases in latencies and reductions in 
amplitudes in hypothyroidism (17, 19–21, 23, 24, 71–73). However, this increase in latency is 
not consistently observed in all cases of hypothyroidism and thus it is still controversial 
after which duration and or severity of hypothyroidism significant increases in latency can 
be observed (74). Nevertheless, blink reflex prolongation could be consistently observed in 
hypothyroid patients confirming a slowing in visual pathways in adult onset 
hypothyroidism (75). From the available studies no definitive conclusion concerning the 
targets for thyroid hormone action in the visual pathways can be drawn. Thyroid hormone 
could already effect photoreceptor sensitivity as well as increase the speed of impulse 
propagation and synaptic transmission in any of the following relay stations. 
Cognitive performance 
Several reports have described mental changes in hypothyroidism, ranging from difficulties 
to perform simple calculations to memory impairments and finally to hallucinations (76–79). 
Although these impairments are probably the most troublesome symptoms for the patients, 
it has been difficult to quantify cognitive problems in adult-onset hypothyroidism. Daytime 
sleepiness as well as mental and physical fatigue are complaints in 70 - 80% of the 
hypothyroids (80, 81). Disturbances of sleep during thyroid dysfunction might account for 
some of the problems delineated above, as the different sleep stages are necessary for 
memory consolidation (82, 83). Sleep fragmentation in hypothyroids is not necessarily 
caused by nocturnal breathing disorders (sleep apnea) (84, 85).  
The trail making test, which tests skills including vigilance, concentration, visual scanning 
and visuomotor tracking speed was shown by Reitan (44, 86) to respond to different types of 
organic brain damage. Later on slowed performance on the trail making test (part B) was 
shown in hypothyroid patients (78, 87). Subsequently Osterweil et al. (24) observed that the 
performance for Trail A was significantly slowed in old and very old hypothyroid patients 
as compared to age-matched controls and Wahlin et al. (88) reported that TSH was 
predictive for Trail-B in very old persons. Our finding of a non-significant slowing in the 
trail making tests confirms the observation of Osterweil et al., that carcinoma patients off 
thyroid hormone replacement show no statistically significant differences in test 
performance compared to euthyroid controls. However, 5 of the six persons tested showed 
an increase in performance when retested after hormone replacement, which escaped 
statistical significance because of the large scatter between the different individuals. This 
suggests that thyroid hormone withdrawal of longer duration is necessary before changes in 
this test become statistically significant. 
Apart from this relatively simple test effects of thyroid hormone on more complex cognitive 
tasks have been investigated. The first measurement of an increase in the intelligence level 
by a mean of 20 I. Q. points of three adult myxedematous patients after three months of 
treatment with thyroid hormone has been reported by Crown (32). Especially in older 
hypothyroid persons, reversible decreases in the Folstein mini mental state score were found 
(24, 89, 90). In a double-blind study on adult persons with subclinical hypothyroidism out of 
17 patients 4 showed improved performance on at least two and 7 test persons improved in 
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one of a reaction time, an object memory and a figure identification test after a six month 
period of thyroxine supplementation (33). Likewise, in subclinically hypothyroid adults the 
Wechsler Memory Scale indicated a significant decrease in logical memory (91, 92) as well as 
verbal and visual memory (93) (for a recent review see (94)) and severe hypothyroidism for 
a short time decreased working memory (43). Using fMRI changes in hypothyroid subjects 
during working memory tasks could be visualized (95). Finally also changes in the 
estimation of time spans have been observed in hypothyroid subjects (96). All these 
experiments were performed after a longer period of hypothyroidism or latent thyroid 
dysfunction. To be able to complete our test battery in a reasonably short time we designed 
a short tests for calculation and visual-spatial performance. Our present results indicate that 
a severe hypothyroidism of a short duration already causes significantly slowed 
performance in a visuo-spatial orientation task. This is in line with findings of increased 
latencies of event-related evoked potentials in hypothyroidism (97, 98). 
Perception of smells 
Although perversions of taste and smell during myxoedema have already been noticed in 
the first descriptions of this disease (99, 100) there have only been a few investigations on 
this subject, which provided no clear answers concerning the prevalence of olfactory 
disorders during hypothyroidism. Reversible increases in the threshold of smell and taste 
have previously been found in hypothyroid subjects (30, 31, 101). In addition to the reduced 
threshold, hypothyroid persons rated bitter and salty tastes as more agreeable than 
euthyroid control persons in the latter study. Interestingly, a more general study concerned 
with smell and taste disorders reported a more than average complaint of patients taking 
levothyroxine about a loss of the sense of taste. The investigation of these patients revealed, 
in contrast to their subjective impressions, higher scores on a taste-identification test. 
Additionally, the patients taking thyroxine perceived a test concentration of coffeine as 
having a greater intensity as the other patients, without showing significantly different taste 
thresholds (102). The discrepancy between subjective impression and test results could have 
resulted from increases in thresholds of taste preceding hormone substitution resulting in an 
increased awareness of the sense of smell. A study of taste thresholds, measured in 11 
hypothyroid subjects after total thyroid ablation, which had stopped taking replacement for 
4-8 weeks prior to a 131I scan showed no increases in recognition thresholds to NaCl and urea 
(103). These patients showed, however, a decrease in intensity rating for the two tastants and 
less dislike to both substances at higher concentrations as compared to control subjects. 
Although the authors conclude that hypothyroidism probably has to persist for a longer time 
in order to develop more pronounced changes in taste, the preference and intensity rating 
tests could indicate the beginning of changes in taste after this period. Our present findings of 
an insignificant tendency towards a higher threshold of smell for both odours in the 
hypothyroid compared with the euthyroid subjects are in line with the assumption of a 
beginning loss of taste and smell after 4 weeks of hypothyroidism. In contrast, however, a 
study by Lewitt et al. (104) found no significant changes in the thresholds for taste and smell 
even in longer standing hypothyroidism. Since this study, in addition, reported no increase in 
the latencies of visual evoked potentials, in contrast to seven other available reports, it could 
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be possible, that the discordant findings of this report were due to the high median age of the 
investigated subjects (61 ± 16 years) which could already have displayed age-dependent 
declines in sensory function. In addition, the possibility exists, that only a fraction of the 
hypothyroid subjects shows changes in taste thresholds (105).  
Possible causes of a loss in smell during hypothyroidism have also been investigated in rats. 
Here prolonged hypothyroidism has been shown to result in deficits in migration of 
olfactory receptor neurones while the mitotic rates of basal cells remained unaltered in 
postnatal (106) as well as in adult rats (107). The effects of propylthiouracil (PTU) – induced 
hypothyroidism were reversed by thyroxine therapy. Further experiments could, however, 
not confirm increases in the threshold to olfactory and taste stimuli in adult rats rendered 
hypothyroid with PTU for 5 weeks (108, 109) in which only changes in taste preferences for 
sour, bitter and salty, not of detection threshold were found. Additional confusion arose 
from several case reports describing thyreostatic drugs to also induce decreases in the sense 
of taste and smell in patients (methylthiouracil, - (110); methimazole - (111); thiamazol and 
carbimazol, (112–114). Sometimes, only the sensation of taste, sometimes also olfaction was 
impaired. Some patients could have actually become hypothyroid, but in some patients no 
other symptoms of hypothyroidism were noted and the symptoms did not reappear during 
thyroidectomy-induced hypothyroidism (110). A histological examination showing 
destruction of the olfactory epithelium, sparing the basal cells already after 32 hours of 
methimazol administration to rats further substantiates the possibility of toxic effects of 
antithyroid medication (115), which lead to apoptosis of rat olfactory receptor neurons (116). 
However, in studies of methimazol toxicology effects of hypothyroidism should be carefully 
excluded. Likewise, we cannot presently exclude, that changes in taste, which have been 
reported to occur frequently in patients as side effects of a high dose 131I therapy (117) could 
also have resulted to some extent from the accompanying hypothyroidism, which also has 
been reported as a potential cause of a “bourning mouth symptom” (118). 
Hearing 
Impairments of hearing have long been reported to occur in hypothyroidism (for reviews 
see (27, 119)). The incidence of decreases in hearing threshold observed in hypothyroid 
patients varies from study to study, ranging from 85% (28), 80% (29), 62% (120), 55% (121) 
43% (122), 31% (80) to as low as 12% [98]. 
The only study showing no evidence of reversible hearing losses in hypothyroid patients 
(123) was performed on old patients between 61-92 years, in which the effects of 
presbyacusis may have a stronger effect on hearing threshold than those of thyroid 
hormone. The most dramatic hearing impairments arise if the thyroid hormone supply is 
insufficient during development, where irreversible structural impairments in the cochlea, 
presumably a disruption of the smooth fit of the tectorial membrane to the hair cells occurs 
(see e.g. (124–126). While a thyroid-hormone induced selective expression of neurotrophin-
receptors could underly the morphogenetic changes shaping the inner ear (127) the 
acceleration of the expression of a fast potassium conductance (128) and the development of 
rapidly activating Ca2+- and voltage-activated K+ (BK) conductances in inner hair cells (129) 
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could be necessary for the proper development of cochlear sensory transduction. 
Furthermore, hypothyroidism causes delays in the development of synaptic inhibition in the 
auditory brainstem (130). In line with a larger susceptibility of the immature auditory 
system to thyroid hormone deficiency Heinemann (131) reported no case of hearing 
impairment in 23 patients with primary hypothyroidism if treated in time but in 4 out of 7 
cases if hormone substitution had been delayed. Besides the irreversible effects of thyroid 
hormone on the development of inner ear function, reversible changes of hearing acuity 
have already been described in early reports on the symptoms of adult-onset 
hypothyroidism (132, 133). Improvements of hearing threshold with treatment in some pa-
tients with hypothyroidism have since been shown with pure tone audiometric testing (25, 
28, 29, 134, 135). Especially noteworthy in this context is the finding, that in 7- 11 year old, 
normal, but latently hypothyroid schoolchildren living in endemic areas of severe iodine 
deficiency iodine prophylaxis led to an average improvement of hearing (30 children tested 
in each village) by 15 db over the course of three years (136). Smaller changes in hearing 
threshold were reported after a total thyroid hormone withdrawal for a few weeks: 6 - 12 
weeks after hormone withdrawal Post (137) reported 26 normal audiograms, decreased 
hearing thresholds which did not reverse after 3- 12 months of treatment in 5 patients and 
small, partially subjective improvements with hormone substitution in 4 patients from a 
total of 35 patients. No acute changes in hearing were also found by Mra and Wax (138) in 
10 patients 2-6 weeks after total thyroidectomy. In contrast, Rubenstein et al. (120) described 
a case of a reversible hearing loss of 20 dB in a 5 year old child, that had been induced by 
stopping thyroid hormone therapy for four weeks. Another case report, where audiometric 
investigations were available 2 months before thyroidectomy a high frequency hearing loss 
started on the 40th day of hormone withdrawal, which was partially reversible after 
hormone substitution (139). These inconsistent findings correspond to our results of 
borderline significant increases in hearing thresholds of about 8 dB for high frequencies after 
4 weeks of thyroid hormone withdrawal. 
Animal experiments showed that in guinea pigs thyroid ablation caused decreased 
amplitudes of cochlear microphonic potentials (140) and cochlear action potentials of 
decreased amplitudes and increased delay when recorded four to eight months after 
administration of an ablative dose of radioactive iodine (124). Likewise, increased hearing 
thresholds have been observed in adult guinea pigs (125) at high frequencies of 8kHz (141) 
after 120 days of hypothyroidism. In contrast, Ritter (26) measured only deafness in five out 
of 166 experimental rats rendered hypothyroid on the 21st day of life. Interestingly, changes 
in the number of spines/per shaft of pyramidal neurones (indicating synaptic densities) could 
be shown in the auditory cortex of adult rats thyroidectomized at 120 days of age and 
investigated 120 days later (142). The authors note that in auditory pyramidal cells these 
changes develop much more slowly than in pyramidal cells of the visual cortex, which could 
indicate that the adult auditory system may respond to hypothyroidism on a slower time 
scale than the visual system. Perhaps these considerations could also explain why, in contrast 
to visual evoked potentials which consistently show slowing in hypothyroidism, some 
authors found no changes in auditory evoked potentials (24, 143) while other studies (18, 21, 
22) found reversible increases in latencies of auditory evoked potentials in hypothyroidism.  
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Taken together, the auditory system may lose its sensitivity to thyroid hormone with in-
creasing age and this may also depend on an individual susceptibility. In addition, effects 
on hearing may develop only after a thyroid hormone withdrawal for more than five weeks 
in the adult. 
Effects of thyroid hormone on sensory perception and brain function  
The present tests performed on a small number of patients indicate that the most prominent 
symptom after 4 weeks of thyroid hormone withdrawal is a beginning decline in the speed of 
central neuronal information processing, which was reflected in decreases in the speed of 
visual perception, speed of speech as well as of visual-spatial orientation. Hearing and 
smelling thresholds were only slightly changed, and in the context with the publications 
discussed above this indicates that auditory and olfactory perception may change only with 
thyroid dysfunctions of longer duration or are more sensitive to thyroid hormone in 
development. The experiments illustrated here complement previous findings, that 
hypothyroidism slows peripheral conduction velocity (144), reduces EEG frequencies and 
increases latencies of evoked potentials (73). The conception that thyroid hormone deficiency 
causes a general decrease in neuronal excitability was recently supported by the observation 
of a decreased cortical excitability and increased motor thresholds using transcranial 
magnetic stimulation in adult patients (145). Accordingly, in a small percentage of epileptic 
seizures in humans (146) thyrotoxicosis was identified as sole cause of the seizures and the 
seizures were found to fully subside after restoration of euthyroidism, again indicating an 
effect of thyroid hormone on cortical excitability. An increased susceptibility to seizures was 
also noticed in hyperthyroid animals such as cats (147) and mice (148). 
5. Explanations of thyroid hormone effects on the brain at the molecular 
and cellular level  
Owing to the complex actions of thyroid hormone there is currently no concluding explanation 
concerning the molecular mechanisms underlying the effects of thyroid hormone on cortical 
excitability. At the morphological level, in the mature brain thyroid hormone excess (149) as 
well as deficiency (150) have been reported to decrease the number of dendritic spines, 
assumed to represent postsynaptic endings, already after 5 days in adult rats. Even more 
dramatically, hypothyroidism leads to a reduction of the neuropile in CA1 and CA3 
hippocampal areas and in addition to a loss of pyramidal cells in the CA1 area (151). Thus it 
seems possible that adult-onset hypothyroidism may actually cause neuronal degeneration, as 
already occasionally observed in autopsies of early cases of patients who had died with 
myxedema (152, 153). A reversible shrinkage of neuropile could also explain the findings of 
reversibly widened ventricular spaces in the brains of hypothyroid subjects (154, 155).  
The development of cholinergic terminals in rat forebrain, hippocampus and amygdala is 
regulated to a considerable extent by thyroid hormone (see e.g. (156)). Although smaller and 
more localized effects are reported in adults, several lines of evidence suggest that 
acetylcholine -release may be enhanced by thyroid hormone and decreased in hypothyroidism 
in the adult nervous system as well (157, 158). A decrease of cholinergic activity could perhaps 
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also explain the occurrence of slow EEG waves (159) as well as the cognitive impairments 
frequently seen in hypothyroid subjects. A regulation of cholinergic function also fits to the 
observation of a regulation of nerve growth factor which has been suggested to be involved in 
maintaining the function of cholinergic hippocampal projections by thyroid hormone in adult 
rat brain (160). Thyroid hormone, however, does not seem to interfere exclusively with 
cholinergic forebrain neurons but to regulate the balance of a variety of other 
neurotransmitters in a region-specific manner. Hence dopamine levels were found to be 
increased in the midbrain of hyperthyroid rats (161) and decreased in hypothyroid rats (162). 
Also the dopaminergic input into striatal neurons could be upregulated by thyroid hormone 
(163). Furthermore, a differential regulation of serotonin levels (162, 164) as well as 5-HT2 
receptors have been found (165). Regulations of various adrenoceptors as well as GABA- 
receptors have been described see e.g. (166–168). In addition T3 could act as a cotransmitter to 
modulate noradrenergic action (169) or as a modulator of endogenous benzodiazepine action 
(170). While it is believed that thyroid hormone exerts its effects predominantly via nuclear 
receptors possible direct effects on membrane receptors further complicate the picture (157, 171, 
172). In addition to a membrane action via αVβ3intergins, high doses of 20 µM T3 or T4 have 
been shown to directly act on GABA receptors to down-regulate GABAergic postsynaptic 
currents in cultured hippocampal neurons (173, 174), which could explain acute increases in 
neuronal excitability induced by iontophoretecally injected T4 and T3 (171). Although the 
regulatory influences exerted by thyroid hormone are complex it seems that T3 regulates to 
some extent the release of neurotransmitters such as acetylcholine, dopamine, 5-HT and 
noradrenalin in specific pathways as well as the density of the corresponding receptors (166).  
A stimulating effect of thyroid hormone on transmitter synthetic enzymes or precursor-
uptake systems as well as the protein synthesis of the receptors could in principle explain 
the decrease in cerebral responsiveness in hypothyroid subjects. Furthermore, a down-
regulation of postsynaptic inhibitory currents in hyperthyroidism, as suggested by Puia and 
Losi (174), could account for the increased irritability seen in hyperthyroid subjects. A 
diminished postsynaptic current density due to a decrease in transmitter release or receptor 
density or activation could also explain some of the increased latencies since a smaller 
current density would lead to a delay in the charging of the membrane capacitance. 
However, investigations using transcranial magnetic stimulation provided evidence that in 
hypothyroid patients the cortical excitability as such is decreased (145). Furthermore, 
experiments on peripheral nerves of hyperthyroid rats indicated enhanced afferent spikes 
and a drop in the chronaxia for direct activation of action potentials in rat peripheral nerves 
(175). Hence thyroid hormone could also influence neuronal excitability directly, which 
could secondarily result in a decrease in transmitter release. 
Changes in conduction velocity, action potential waveform and the regulation of voltage-gated ion 
currents by thyroid hormone 
Changes in Achilles tendon reflexes and the slowing of peripheral conduction velocity in 
hypothyroidism have so far mostly been explained by a reduction in myelination, and the 
gene for myelin basic protein is, in fact, regarded as one of the few genes known to be 
directly regulated by thyroid hormone (for review see (176)). However, a decrease in 
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sodium current density could as well explain the decreases in peripheral conduction 
velocities and increases in latencies of evoked potentials found in hypothyroidism (16–24) 
and reversely the increased amplitudes in hyperthyroidism (177, 178). Since there seems to 
be an optimal density of sodium channels that ensures maximal neuronal conduction 
velocity (179), beyond which no further increase or even a slowing of conduction velocity 
occurs, an upregulation of sodium currents by thyroid hormone could also explain the 
inconsistent findings concerning latencies of evoked visual potentials in hyperthyroidism, 
where some authors found decreases in latencies (180) or even increases with increases in 
thyroid hormone (21, 71, 177, 178). Because of the temperature sensitivity of the activation of 
sodium and calcium currents the fall in core temperature during hypothyroidism and its 
increase in hyperthyroidism could further exacerbate the symptoms (19). 
Influences of thyroid hormone on action potentials and underlying ion currents in the heart 
Evidence that thyroid hormone could indeed change action potential waveforms became 
available from electrical recordings performed in ventricular cells from guinea pig hearts, that 
showed decreases in action potential length in the course of hours after application of thyroxine, 
which then gradually recovered over the course of days (181). In line with these observations, 
prolongations of action potential durations were observed in hypothyroid rat heart cells (182) 
and guinea pig ventricular myocytes (183). That thyroid hormone directly effects the electrical 
properties of heart cells, and not just alters sympathetic receptors was shown by Valcavi et al. 
(184), who demonstated an increase in the intrinsic activity of the sinus node in hyperthyroid 
patients that persisted after chemical blockage of autonomous innervation. Patch clamp 
recordings revealed that in heart cells from neonatal rats (185, 186) and in cat atrial myocytes 
(187), acute applications of 5-20 nM T3 increased voltage activated sodium currents. Single 
channel recordings revealed that the application of 5-50 nM T3 induced bursting of Na+-
channels in rabbit ventricular myocytes (188). Later studies showed, that T3 increases the 
sodium channel open probability by binding directly inside the membrane and that the 
interaction with a pertussis toxin sensitive G-protein greatly enhances this effect (189). More 
recent experiments by Schmidt et al. (190), confirmed rapid effects of T3 on human hearts, 
however, suggesting a contribution of the sympathetic nervous system. After a period of 
prolonged hyperthyroidism in rats, in contrast to acute effects, no changes in Na+current density 
as well as of inward potassium currents were found. At that time increased rates of rise of the 
action potentials could be rather explained by an increase in Ca2+-currents and a shortened 
action potential duration by an increase in a delayed rectifier current (191). Although it is 
presently not completely understood, which channel regulations exactly determine short and 
long term effects of thyroid hormone, it is safe to conclude, that an upregulation of voltage 
activated Na+-, Ca2+ and K+-currents plays a pivotal role in decreases in action potential duration, 
the acceleration of the heart beat and modulation of contraction amplitude by thyroid hormone. 
Influences of thyroid hormone on action potentials and underlying ion currents in the central 
nervous system 
The influence of thyroid hormone on the electrical properties of neurons has been studied in 
less detail. The first experiments using whole cell patch clamp recordings were carried out 
on cultured postnatal rat hippocampal neurons and showed an upregulation of voltage-
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gated Na+-currents (INav) by T3 (192). An upregulation of the density of voltage-gated Na+ 
currents was also found in acutely isolated neurons from the occipital cortex of 
hyperthyroid rats and a down regulation observed in cells from hypothyroid rats. The 
changes in Na+current density led to increased action potential upstroke velocities as well as 
to enhanced discharge rates in thyroid hormone treated cells in response to identical 
stimulus strengths (193). Similarly, increases in voltage-gated Na+ currents were observed in 
human neuroepithelial cells as well as mesenchymal stem cells after incubation with 1 nM 
T3 for 72h to 6 days in culture. Neuroepithelial cells additionally responded with increases 
in Ca2+ currents to prolonged T3-treatment (194). In the in vivo situation thyroid hormone 
effects seem to be more complex: Thus in CA1 neurons of the rat hippocampus changes in 
the bursting pattern have been observed, which could be explained by an upregulation of a 
low-threshold Ca2+ current (195). Furthermore, consistent with Hoffmann and Dietzel, 2004, 
decreases in action potential depolarization rate and decreases in discharge rate were 
observed by thyroid hormone withdrawal. In contrast to the action of thyroid hormone in 
the heart these authors additionally observed a shortening of action potental duration upon 
thyroid hormone withdrawal, that could be explained by the upregulation of an A-type 
potassium current (196). Finally in a somewhat distant animal, in Rohon-Beard neurons 
from the embryonic zebrafish rapid increases of voltage-gated Na+currents by thyroxine 
were found (197). This Na+current regulation was shown to be essential for the further 
development of the embryo and depended on αVβ3 integrin activation and the MAPK (p38) 
pathway (198). An increase in voltage-gated Na+current density by thyroid hormone would 
cause a general speeding of mental functions as illustrated in figure 5: 
 
Figure 5. Simulation of action potential spread in a hippocampal model neuron, for action potential 
with high (A-red) and low (A-blue) Na+-current density. A an increase in Na+current density increases 
action potential depolarization (Aa), amplitude and discharge frequency (Ab). B. Simulation of action 
potential spread in a ramified neuron 1 ms after application of a stimulus at t=1ms. 
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B shows the spread for the neuron with high current density and B for the neuron with 
low current density. The magnified inserts (Ba and Cb) clearly show, that the overshoot 
of the action potential (light colours) reaches the synapses much earlier in the cell with 
high current density than in the cell with lower current density (Cb). Simulations 
performed using the Hodgkin-Huxley equations and the program Neuron version 3.2.3 
(199). 
Hypothyreosis also affects a prominent EEG pattern, namely the alpha rhythm (11–15). This 
may be also related to altered Na+ channel function, since TTX-insensitive Na+ currents of 
cortical bursting neurones have been implicated in the generation of the alpha rhythm (200). 
Subsequently, the presence of SCN5A mRNA, encoding the TTX-resistant Na+ channel had 
been demonstrated in the mammalian brain (201, 202). 
It is noteworthy that the mental symptoms observed with the psychophysical tests used in 
the present study developed gradually, as most prominently demonstrated in the 
continuous observations on a single person and only recovered with a similar slow time 
course in the first weeks of hormone resubstitution (see Fig. 1D and 2A). Prolonged recovery 
phases for the reversal of several of the symptoms accompanying hypothyroidism have 
been described (20, 84, 203–205) and subjective improvements of well-being, quantified with 
a “Quality of life-Thyroid scale” were found only after four weeks compared to one week of 
thyroid hormone replacement (38). 
This corresponds to the observation of a lack of acute effects of T3 in hippocampal slices 
(206) and the observation of a slow upregulation of Na+current density in hippocampal 
cultures (207). In the later study the Na+current regulation was shown to depend on the 
presence of glial cells in the culture medium. Thyroid hormone has been shown to induce 
protein secretion from glial cells (208), including basic fibroblast growth factor (FGF-2) (209) 
and epidermal growth factor (210). Furthermore, thyroid hormone has been shown to 
elevate nerve growth factor, neurotrophin-3 and brain derived neurotrophic factor (BDNF) in the 
brain (see e.g.(211)). A first indication that intermediate steps, including growth factors 
could be involved in the regulation of Na+currents by thyroid hormone were experiments, 
that showed, that the effect of T3 on Na+ currents could be reduced by a simultaneous 
incubation of cultures with antibodies against FGF-2, leading to the hypothesis depicted 
in Figure 6. 
Concerning the action of thyroid hormone on neuronal excitability there seems to be a 
common finding that the density of voltage-gated Na+currents is up-regulated by thyroid 
hormone rendering the cells more excitable. This mechanism would explain many of the 
symptoms observed in thyroid disease, such as slowed peripheral conduction velocity and 
decreased excitability of the hypothyroid brain. In other tissues, such as various epithelial 
cells, thyroid hormone could, likewise, play an essential role in the regulation of the 
expression of amiloride sensitive, epithelial Na+channels (see e.g. (212)). The molecular 
mechanisms, leading to Na+current upregulation, may however, differ in different species 
and tissues and warrant further elucidation. 
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Figure 6. Illustration of a potential mechanism leading to Na+-current regulation in the hippocampus of 
rats: T3 stimulates glial cells (stained red by antibodies against GFAP) to secrete growth factors (such as 
FGF-2) which in turn up-regulate Na+currents in neurons. (stained green by antibodies against βIII 
tubulin). Thus in addition to regulating the neuronal environment and stimulating synapse formation 
glial cells could also be involved in modulating neuronal excitability.  
Regulation of Na+/K+-ATPase expression by thyroid hormone 
Since thyroid hormone has long been known to increase energy expenditure, and about 40% 
of energy at rest is consumed by activity of the Na+/K+-ATPase (36, 37, 213) many 
researchers focused on studying effects of thyroid hormone on Na+/K+-ATPase activity and 
expression. The Na+/K+-ATPase is a heterodimeric membrane spanning protein complex 
composed of three catalytic alpha subunits (α1, α2 and α3) with molecular weights of ~97-
116kDa and two glycosylated β subunits (β1 and β2 of ~35-55kDa). While the α subunits 
contain the Na+, K+ and the intracellular ATP binding site, the β subunits are required to 
insert the catalytic α subunits into the appropriate locations of the cell membrane (214). An 
intracellular Na+ load of the cell leads to binding of three Na-ions to their intracellular 
binding sites, thus triggering phosphorylation of the α subunit and inducing a 
conformational change of the pump to expose the Na-ions to the extracellular surface at the 
expense of ATP (see e.g. (37)). Thus an increased intracellular Na+-load, as induced by a 
larger or longer Na+ influx will increase energy consumption by stimulating the demand for 
ATP. Interestingly, the Na+/K+-ATPase shows a 10-12 fold increase in expression during 
postnatal development of the brain (215) which parallels the postnatal increase in Na+ 
current density (216).  
The different isoforms of the Na+/K+-ATPase were reported to be distributed in a cell and 
tissue dependent manner. Thus in brain tissue the α3 isoform transcript is expressed 
abundantly in comparison with the mRNA for the α1 and α 2 subunits. The α3 expression 
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increases 10 fold within the first 7 days after birth and remains at this elevated level until the 
55th day of age in the rat. In contrast, the mRNA for the α1, α2 and β isoforms reach their 
maximal expression levels only after the rats are at 25 days old (215).  
In general, thyroid hormone was found to up-regulate Na+/K+-ATPase activity and 
expression in many tissues: For instance, in rat cardiomyocytes, T3 was observed to increase 
the mRNA pattern of Na+/K+-ATPase α1 and β1 subunits 4fold after 48hrs and the α2 mRNA 
expression even 7fold after 72hrs of treatment (217). A similar effect of T3 was found in a rat 
liver cell line. Here, a non transformed continuous cell line derived from adult rat liver 
treated with T3 showed a 1.3 fold increased activity of Na+/K+-ATPase. More specifically, the 
mRNA expression of the α1 and β1 isoforms of the Na+/K+-ATPase increased 1.5 and 2.9 fold 
respectively compared with controls maintained in T3 free (hypothyroid) media (218). 
In rat brains thyroid hormone has been shown to up-regulate Na+/K+-ATPase activity and 
protein expression in synaptosomes only in the first two postnatal weeks (219). In addition 
Schmitt et al., in 1988 showed that the hypothyroid condition reduces the expression of the 
mRNA for Na+/K+-ATPase α isoforms in rat brain (220). However, observing thyroid 
hormone effects in identified brain regions in the adult rat indicated, that hypothyroidism 
could down-regulate Na+/K+-ATPase activity in specific brain regions, such as the adult 
hippocampus (221, 222). Further experiments showed that the predominant brain cell 
specific α3 isoform of the Na+/K+-ATPase decreased in hypothyroid rat brain as well and 
that the relative sensitivity of the different Na+/K+-ATPase α subunits in brain cells for 
thyroid hormone is α3>α1>α2 (223). The expression of all Na+/K+-ATPase isoforms and their 
regulation by T3 was also observed in primary neuronal cell cultures of rat brain at the 
mRNA and protein level using northern and western blot techniques (224). In contrast to 
neurons, glia cells express α1, α 2 and β1, 2 not α3. The mRNAs as well as the proteins of the 
four subunits expressed in glia cells showed an upregulation when the cells were grown 
with the supplement of T3 for 5 and 10 days respectively (225).  
Although a T3-responsive element has been found in the promotor region of the α3 subunit 
(226) two reports on muscle cells indicate, that the regulation of the Na+/K+-ATPase by 
thyroid hormone might be at least to some extent secondary to an enhanced sodium influx. 
Thus Brodie and Sampsom (227) observed that a blockage of Na+-influx by tetrodotoxin to 
block the voltage-gated Na+currents or by amiloride to block further Na+transport routes 
both reduced the T3-induced increase of 3[H]-ouabain binding sites, which represent 
membrane inserted Na+/K+-ATPase in cultured myotubes. These results were confirmed by 
Harrison and Clausen (228) in skeletal muscle, who showed that an increase in saxitoxin 
binding (reflecting Na+channel density) preceded an increase in 3[H]-ouabain binding 
(reflecting membrane inserted Na+/K+-ATPases). These experiments indicate a link between 
Na+ current regulation and the regulation of the Na+/K+-ATPase by thyroid hormone. This is 
in agreement with other experiments in chick skeletal muscle that suggested that the 
activation of voltage-gated Na+channels by veratridine leads to an increased biosynthesis of 
Na+/K+-ATPase in chick myogenic cultures (229). Whether these findings also apply to 
neurons, or whether some subunits are regulated directly by thyroid hormone receptors and 
others are regulated by the sodium load of the cells remains, however, to be clarified. 
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6. Conclusions 
Thyroid hormone deficiency leads to a general slowing of many body functions, including a 
slowing of heart rate, a slowing of intestinal movements as well as of thoughts and 
movements. As demonstrated here in an exemplary fashion on a small sample of patients 
the most conspicuous symptom to develop during a short period of severe hypothyroidism 
is a gradual, quantifiable slowing of speech and of critical flicker fusion frequency. 
Although several explanations at the cellular and molecular level are feasible an intriguing 
hypothesis is, that a central aspect of the origin of many of these symptoms might be a 
regulation of the sodium current density that is a key player of neuronal and cellular 
excitability. In fact, some effects of thyroid hormone can to some extent be blocked by the 
sodium channel blocker TTX: Thus the upregulation of the membrane Na+/K+ATPase 
expression in myotubes (227) and skeletal muscle (228) as well as of soma growth in L-
GABAergic neurons (230) by thyroid hormone were all to some extent blockable by TTX, 
suggesting that some effects of thyroid hormone occur downstream of sodium channel 
regulation. In future it will be exciting to elucidate the full signal cascade involved in the 
regulation of the different sodium channel subunits as well as to conclusively sort out the 
primary and the secondary targets of thyroid hormone action. It will be interesting to study 
whether some of these thyroid hormone actions decline in the aging brain. 
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